• FirefoxInstall the new Firefox »
  •  Dow Down0.23% Nasdaq Down0.27%

    Charles River Laboratories International, Inc. (CRL)

    -NYSE
    79.01 Up 0.94(1.20%) Mar 26, 4:02PM EDT
    |Pre-Market : 79.01 4:27PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Charles River Laboratories International, Inc.
    251 Ballardvale Street
    Wilmington, MA 01887
    United States - Map
    Phone: 781-222-6000
    Fax: 978-988-5665
    Website: http://www.criver.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Laboratories & Research
    Full Time Employees:7,900

    Business Summary 

    Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and preclinical development services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also offers a range of services to assist its clients in supporting the use of research models in drug discovery and development comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for identification of a druggable target within a cell through delivery of clinical drug candidates; and safety assessment services, which comprise bioanalysis, pharmacokinetics, drug metabolism, toxicology, and pathology services. The Manufacturing segment provides non-animal or in vitro methods for lot release testing of medical devices and injectable drugs for endotoxin contamination. This segment also offers specialized testing of biologics and devices that are outsourced by pharmaceutical and biotechnology companies; and specific pathogen free fertile chicken eggs and chickens for the manufacture of live viruses. The company serves pharmaceutical and biotechnology companies, contract research organizations, agricultural and chemical companies, life science and veterinary medicine companies, contract manufacturing organizations, medical device companies, diagnostic and other commercial entities, hospitals, academic institutions, and government agencies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Charles River Laboratories International, Inc.

    Corporate Governance 
    Charles River Laboratories International, Inc.’s ISS Governance QuickScore as of Mar 1, 2015 is 2. The pillar scores are Audit: 5; Board: 2; Shareholder Rights: 2; Compensation: 2.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. James C. Foster J.D., 64
    Chairman, Chief Exec. Officer, Pres, Chairman of Exec. Committee and Member of Strategic Planning & Capital Allocation Committee
    2.06M7.53M
    Mr. Thomas F. Ackerman , 60
    Chief Financial Officer and Corp. Exec. VP
    867.00K1.59M
    Dr. Nancy A. Gillett D.V.M, Ph.D., D.A.C.V.P., 59
    Chief Scientific officer and Corp. Exec. VP
    918.00K619.00K
    Mr. David P. Johst , 53
    Chief Admin. Officer and Gen. Counsel
    943.00K1.17M
    Dr. Davide A. Molho D.V.M., 45
    Corp. Exec. VP and Pres of Global Research Models & Services & DSA Operations
    942.00K575.00K
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders